Immunizations could be administered within minutes where and when a disease is breaking out.
Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be used. They are expensive to ship and keep refrigerated and they tend to have short shelf lives.
University of Washington engineers hope a new type of vaccine they have shown to work in mice will one day make it cheaper and easy to manufacture on-demand vaccines for humans. Immunizations could be administered within minutes where and when a disease is breaking out.
“We’re really excited about this technology because it makes it possible to produce a vaccine on the spot. For instance, a field doctor could see the beginnings of an epidemic, make vaccine doses right away, and blanket vaccinate the entire population in the affected area to prevent the spread of an epidemic,” said François Baneyx, a UW professor of chemical engineering and lead author of a recent paper published online in the journal Nanomedicine.
In typical vaccines, weakened pathogens or proteins found on the surface of microbes and viruses are injected into the body along with compounds called adjuvants to prepare a person’s immune system to fight a particular disease. But standard formulations don’t always work, and the field is seeking ways to manufacture vaccines quicker, cheaper and tailored to specific infectious agents, Baneyx said.
The UW team injected mice with nanoparticles synthesized using an engineered protein that both mimics the effect of an infection and binds to calcium phosphate, the inorganic compound found in teeth and bones. After eight months, mice that contracted the disease made threefold the number of protective “killer” T-cells – a sign of a long-lasting immune response – compared with mice that had received the protein but no calcium phosphate nanoparticles.
The nanoparticles appear to work by ferrying the protein to the lymph nodes where they have a higher chance of meeting dendritic cells, a type of immune cell that is scarce in the skin and muscles, but plays a key role in activating strong immune responses.
In a real-life scenario, genetically engineered proteins based on those displayed at the surface of pathogens would be freeze-dried or dehydrated and mixed with water, calcium and phosphate to make the nanoparticles. This should work with many different diseases and be especially useful for viral infections that are hard to vaccinate against, Baneyx said.
He cautioned, however, that it has only been proven in mice, and the development of vaccines using this method hasn’t begun for humans.
The Latest on: Vaccines
[google_news title=”” keyword=”Vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vaccines
- COVID vaccines: should people under 50 in the UK be offered a fourth dose?on December 1, 2022 at 4:53 am
We don’t have a lot of scientific evidence on how much additional protection a fourth dose would offer younger adults. But on balance, giving them the option could be worthwhile.
- African continent finally to receive 1st mpox vaccineson December 1, 2022 at 4:15 am
Africa’s top public health body says the continent is set to receive its first batch of mpox vaccines as a donation from South Korea ...
- mRNA vaccines offer one-two punch to combat malariaon December 1, 2022 at 2:39 am
Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year. Vaccines are one intervention that could help eliminate this deadly ...
- Bill Clinton has COVID, but says he's "doing fine overall" thanks to vaccineson December 1, 2022 at 12:39 am
"I'm grateful to be vaccinated and boosted, which has kept my case mild, and I urge everyone to do the same," said the 76-year-old former president.
- Zika Virus Vaccines Market Insights: Industry changing aspects, New Technologies and Forecast to 2028 | Market Growth Reportson November 30, 2022 at 11:35 pm
Zika Virus Vaccines Market Report offers an Complete view about Zika Virus Vaccines market and incorporates a profound picture of execution by a portion of the key global players finishing on the ...
- COVID-19 vaccines are still essential in preventing death in children and teenson November 30, 2022 at 3:30 pm
The study of more than 800,000 children across Argentina reinforces the importance of vaccinating youth in order to prevent death.
- Former vaccines chief sounds warning about UK pandemic readinesson November 30, 2022 at 2:28 pm
Kate Bingham raises concerns to committee of MPs as head of UKHSA suggests Covid could be on rise again ...
- Chicago Health Department will bring COVID boosters, flu vaccines to your home for freeon November 30, 2022 at 10:44 am
The city of Chicago is making it easier than ever to get your COVID booster and flu vaccine. The health department will bring both shots right to your home and it's free. You can make an appointment ...
- Flu and Covid-19 this winter: what you need to know about vaccines and boosterson November 30, 2022 at 3:21 am
The colder weather is a breeding ground for new respiratory viruses that put those living with long-term health conditions at risk of severe illness. This is where vaccines come into their own, helpin ...
- More deaths among vaccinated Americans not a reason to avoid vaccines, experts sayon November 29, 2022 at 5:24 pm
A recent Washington Post headline about vaccinated Americans comprising the majority of COVID-19 deaths has been shared widely on social media to suggest that getting vaccinated i ...
via Bing News